Propanc Biopharma Produces Synthetic Recombinant Proenzymes for Cancer Therapy Targeting Advanced Solid Tumors

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company…

SPG expands turbine technology partnership with Honeywell to include Energy Services market

BROOKSHIRE, Texas--(BUSINESS WIRE)--Signal Power Group (“Signal Power" or “SPG”) announced today an expansion of its…

WNS to Release Fiscal 2024 First Quarter Financial and Operating Results on July 20, 2023

NEW YORK & MUMBAI, India--(BUSINESS WIRE)--$WNS #BPM--WNS (Holdings) Limited (NYSE: WNS), a leading provider of…

Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics

Exclusive License Agreement for an Oncological Target Antibody to Develop Best-In-Class ADC BEIJING & LONDON--(BUSINESS…

Bragg Gaming Content Now Live in Georgia with Adjarabet

Expands Bragg iGaming content to new regulated online gaming market TORONTO--(BUSINESS WIRE)--Bragg Gaming Group (NASDAQ:…

GTJAI Brought ESG Considerations into its Credit Risk Policy

HONG KONG--(BUSINESS WIRE)--Guotai Junan International Holdings Limited (“Guotai Junan International”, the “Group” or “GTJAI”, stock…

ATFX Expands its Global Reach with Acquisition of Rakuten Securities Australia

SYDNEY, AUSTRALIA - Media OutReach - 5 July 2023 - ATFX, a global leading online…

REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMAâ„¢ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program…